Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenue $ 15,718 $ 12,805 $ 40,890 $ 37,200
Cost of revenue (exclusive of amortization shown separately below) 4,553 4,196 11,566 11,725
Gross profit 11,165 8,609 29,324 25,475
Operating expenses:        
Sales and marketing 5,255 6,081 15,116 17,921
Research and development 3,587 5,473 10,673 18,250
General and administrative 11,950 11,899 34,836 35,228
Amortization 1,346 1,352 4,040 3,515
Total operating expenses 22,138 24,805 64,665 74,914
Loss from operations (10,973) (16,196) (35,341) (49,439)
Other (expense) income, net (4) 184 (108) 446
Loss before provision for income taxes (10,977) (16,012) (35,449) (48,993)
Provision for (benefit from) income taxes 36 (1,815) 41 (1,799)
Net loss $ (11,013) $ (14,197) $ (35,490) $ (47,194)
Net loss per share:        
Basic and diluted $ (0.40) $ (0.64) $ (1.31) $ (2.26)
Weighted average shares outstanding:        
Basic and diluted 27,593,315 22,345,122 27,162,880 20,882,293
Comprehensive loss:        
Net loss $ (11,013) $ (14,197) $ (35,490) $ (47,194)
Unrealized gain on marketable securities, net of income taxes       48
Foreign currency translation gain (loss), net of income taxes 6 (31) 11 (8)
Total comprehensive loss $ (11,007) $ (14,228) $ (35,479) $ (47,154)